A Novel Bispecific Anti-GPRC5D × CD3 Antibody: A New Treatment Paradigm in Multiple Myeloma

by | May 21, 2024 | Myeloma News | 0 comments

Source: Pharmacy Times articles

Investigators assessed the efficacy of BsAb5003 in treating multiple myeloma, with the results showing that the therapy may be an effective treatment approach.
Read More

Submit a Comment